| Application no. and date | 05812036.1 (espacenet) (Federated) (European Patent Register), 20051205 | | Patent/reg. no. and date | DK/EP 1824855, 20120808 | | Publication date | 20070829 | | Priority no. and date | SE 0402972, 20041206, SE 0501093, 20050513 | | EP pub. no. and date |
EP 1824855 20070829 | | Effective date | | | Applicant/owner | AstraZeneca AB,
151 85 Södertälje, SE | | Applicant ref. no. | AST 101621 | | Inventor | TIDEN, Anna-Karin, AstraZeneca R & D Södertälje
S-151 85 Södertälje, SE,
BÖGEVIG, Anders, AstraZeneca R & D Södertälje
S-151 85 Södertälje, SE,
LO-ALFREDSSON, Yvonne, AstraZeneca R & D Södertälje
S-151 85 Södertälje, SE,
PIVONKA, Donald
AstraZeneca Wilmington, 1800 Concord Pike,P.O. Box 15437
Wilmington, DE 19850-5437, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/519 (2006.01) , A61P 9/10 (2006.01) , C07D 487/04 (2006.01) | | Title | Hidtil ukendte pyrrolo (3,2-d)pyrimidin-4-onderivater og anvendelser af disse til behandling | | Int. application no. | SE2005001835 | | Int. publication no. | WO2006062465 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
